Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,329 GBp
Change Today -4.50 / -0.34%
Volume 7.8M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 11:35 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Patrick J. T. Vallance

President of Pharmaceuticals R&D, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 36 board members in 2 different organizations across 4 different industries.

See Board Relationships
----

Background*

Dr. Patrick J. T. Vallance has been the President of Pharmaceuticals R&D at GlaxoSmithKline plc since January 2012. Dr. served as Senior Vice President of Medicines Discovery and Development at GlaxoSmithKline plc since July 2010. Dr. Vallance served as Head of the Division of Medicine of Glaxosmithkline, Plc. Dr. Vallance manages one of the most research- intensive departments of medicine in the UK. He has over 20 years of experience of clinical medicine. He also maintains ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Director
Director

Education*

Unknown/Other Education
University Of London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,328.50 GBp -4.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.